• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

分化良好的胰腺神经内分泌肿瘤的大小与 Ki67 增殖指数相关,与年龄无关。

The size of well differentiated pancreatic neuroendocrine tumors correlates with Ki67 proliferative index and is not associated with age.

机构信息

Pancreatic Surgery Unit, Pancreas Translational & Clinical Research Center, San Raffaele Scientific Institute, "Vita-Salute" University, Milan, Italy.

University Centre for Statistics in the Biomedical Sciences, "Vita-Salute" University, Milan, Italy.

出版信息

Dig Liver Dis. 2019 May;51(5):735-740. doi: 10.1016/j.dld.2019.01.008. Epub 2019 Jan 22.

DOI:10.1016/j.dld.2019.01.008
PMID:30723019
Abstract

BACKGROUND

Concerns exist about a conservative management of well-differentiated nonfunctioning small pancreatic neuroendocrine tumors (NF-PanNET) in young patients and when preoperative Ki67 proliferative index is ≥3%.

AIM

To evaluate an association between age, tumor size and grading in patients with sporadic NF-PanNET who underwent curative resection.

METHODS

Patients who underwent surgery for sporadic NF-PanNET (excluding G3) were retrospectively analyzed. Linear regression analysis was performed to evaluate a possible correlation between continuous variables, whereas multiple logistic regression analysis was performed for determining predictors of NF-PanNET-G2.

RESULTS

Overall, 235 patients with NF-PanNET-G1/G2 were included. The median largest radiological diameter was 25 mm. Age correlated neither with tumor size (P = 0.675) nor with Ki67 index (P = 0.376). On multivariate linear regression analysis, factors independently associated with Ki67 index were NF-PanNET size (P = 0.031), perineural invasion (P = 0.004), microvascular invasion (P = 0.001) and necrosis (P = 0.009). The most accurate NF-PanNET size for predicting NF-PanNET-G2 was 25 mm. On multivariate analysis, a NF-PanNET size >25 mm was independently associated with the risk of having a PanNET-G2 (P = 0.025).

CONCLUSION

No correlations exist between age and NF-PanNET size or proliferative index. Therefore, an a priori aggressive attitude is not justified in young patients with small NF-PanNET, as a long-life expectancy is probably unlikely to increase the risk of malignant transformation.

摘要

背景

对于年轻患者和术前 Ki67 增殖指数≥3%的分化良好的非功能性胰腺神经内分泌肿瘤(NF-PanNET),存在保守治疗的担忧。

目的

评估行根治性切除术的散发性 NF-PanNET 患者的年龄、肿瘤大小和分级之间的关系。

方法

回顾性分析接受手术治疗的散发性 NF-PanNET(不包括 G3)患者。进行线性回归分析以评估连续变量之间的可能相关性,而进行多变量逻辑回归分析以确定 NF-PanNET-G2 的预测因素。

结果

共纳入 235 例 NF-PanNET-G1/G2 患者。最大影像学直径的中位数为 25mm。年龄与肿瘤大小(P=0.675)和 Ki67 指数(P=0.376)均无相关性。多变量线性回归分析显示,与 Ki67 指数独立相关的因素包括 NF-PanNET 大小(P=0.031)、神经周围侵犯(P=0.004)、微血管侵犯(P=0.001)和坏死(P=0.009)。预测 NF-PanNET-G2 的最准确 NF-PanNET 大小为 25mm。多变量分析显示,NF-PanNET 大小>25mm 与发生 PanNET-G2 的风险独立相关(P=0.025)。

结论

年龄与 NF-PanNET 大小或增殖指数之间无相关性。因此,对于年轻的小 NF-PanNET 患者,没有理由预先采取激进的态度,因为预期寿命较长不太可能增加恶性转化的风险。

相似文献

1
The size of well differentiated pancreatic neuroendocrine tumors correlates with Ki67 proliferative index and is not associated with age.分化良好的胰腺神经内分泌肿瘤的大小与 Ki67 增殖指数相关,与年龄无关。
Dig Liver Dis. 2019 May;51(5):735-740. doi: 10.1016/j.dld.2019.01.008. Epub 2019 Jan 22.
2
Recurrence of Pancreatic Neuroendocrine Tumors and Survival Predicted by Ki67.Ki67 预测胰腺神经内分泌肿瘤的复发和生存。
Ann Surg Oncol. 2018 Aug;25(8):2467-2474. doi: 10.1245/s10434-018-6518-2. Epub 2018 May 22.
3
Association between preoperative Vasostatin-1 and pathological features of aggressiveness in localized nonfunctioning pancreatic neuroendocrine tumors (NF-PanNET).术前 Vasostatin-1 与局限性无功能性胰腺神经内分泌肿瘤 (NF-PanNET) 侵袭性病理特征的关系。
Pancreatology. 2019 Jan;19(1):57-63. doi: 10.1016/j.pan.2018.11.005. Epub 2018 Nov 14.
4
The high-grade (WHO G3) pancreatic neuroendocrine tumor category is morphologically and biologically heterogenous and includes both well differentiated and poorly differentiated neoplasms.高级别(世界卫生组织G3级)胰腺神经内分泌肿瘤类别在形态学和生物学上具有异质性,包括高分化和低分化肿瘤。
Am J Surg Pathol. 2015 May;39(5):683-90. doi: 10.1097/PAS.0000000000000408.
5
The Impact of Phosphohistone-H3-Assisted Mitotic Count and Ki67 Score in the Determination of Tumor Grade and Prediction of Distant Metastasis in Well-Differentiated Pancreatic Neuroendocrine Tumors.磷酸化组蛋白H3辅助有丝分裂计数和Ki67评分在高分化胰腺神经内分泌肿瘤的肿瘤分级判定及远处转移预测中的作用
Endocr Pathol. 2016 Jun;27(2):162-70. doi: 10.1007/s12022-016-9424-9.
6
Risk factors for short recurrence-free survival after resection of pancreatic neuroendocrine tumor (PanNET) liver metastases: which patients should undergo resection?胰腺神经内分泌肿瘤(PanNET)肝转移切除术后无复发生存期短的危险因素:哪些患者应接受手术切除?
Scand J Gastroenterol. 2020 Apr;55(4):479-484. doi: 10.1080/00365521.2020.1743352. Epub 2020 Mar 30.
7
Neuroendocrine Tumor Heterogeneity Adds Uncertainty to the World Health Organization 2010 Classification: Real-World Data from the Spanish Tumor Registry (R-GETNE).神经内分泌肿瘤异质性给 2010 年世界卫生组织分类带来不确定性:来自西班牙肿瘤登记处(R-GETNE)的真实世界数据。
Oncologist. 2018 Apr;23(4):422-432. doi: 10.1634/theoncologist.2017-0364. Epub 2018 Jan 12.
8
Analysis of risk factors for recurrence after curative resection of well-differentiated pancreatic neuroendocrine tumors based on the new grading classification.基于新分级分类法的高分化胰腺神经内分泌肿瘤根治性切除术后复发危险因素分析
J Hepatobiliary Pancreat Sci. 2014 Jun;21(6):418-25. doi: 10.1002/jhbp.47. Epub 2013 Oct 20.
9
Ki-67 grading of nonfunctioning pancreatic neuroendocrine tumors on histologic samples obtained by EUS-guided fine-needle tissue acquisition: a prospective study.EUS 引导下细针组织获取的组织样本中 Ki-67 分级在非功能性胰腺神经内分泌肿瘤中的应用:一项前瞻性研究。
Gastrointest Endosc. 2012 Sep;76(3):570-7. doi: 10.1016/j.gie.2012.04.477.
10
Impact of Ki67 re-assessment at time of disease progression in patients with pancreatic neuroendocrine neoplasms.胰腺神经内分泌肿瘤患者疾病进展时Ki67重新评估的影响
PLoS One. 2017 Jun 23;12(6):e0179445. doi: 10.1371/journal.pone.0179445. eCollection 2017.

引用本文的文献

1
Decoding Pancreatic Neuroendocrine Tumors: Molecular Profiles, Biomarkers, and Pathways to Personalized Therapy.解读胰腺神经内分泌肿瘤:分子特征、生物标志物及个性化治疗途径
Int J Mol Sci. 2025 Aug 13;26(16):7814. doi: 10.3390/ijms26167814.
2
Pancreatic Neuroendocrine Neoplasms Larger than 4 cm: A Retrospective Observational Study of Surgery, Histology, and Outcome.直径大于4厘米的胰腺神经内分泌肿瘤:一项关于手术、组织学及预后的回顾性观察研究
J Clin Med. 2023 Feb 25;12(5):1840. doi: 10.3390/jcm12051840.
3
The risk and prognostic factors for G1 pancreatic neuroendocrine tumors: A retrospective analysis of the SEER database.
G1级胰腺神经内分泌肿瘤的风险及预后因素:美国监测、流行病学和最终结果(SEER)数据库的回顾性分析
Front Oncol. 2022 Oct 6;12:993524. doi: 10.3389/fonc.2022.993524. eCollection 2022.
4
Reappraisal of a 2-cm Cutoff Size for the Management of Nonfunctional Pancreatic Neuroendocrine Tumors: A Population-Based Study.重新评估 2cm 作为功能性胰腺神经内分泌肿瘤治疗的截断值:一项基于人群的研究。
Front Endocrinol (Lausanne). 2022 Jul 18;13:928341. doi: 10.3389/fendo.2022.928341. eCollection 2022.
5
Endoscopic ultrasound-guided side-fenestrated needle biopsy sampling is sensitive for pancreatic neuroendocrine tumors but inadequate for tumor grading: a prospective study.内镜超声引导下侧方开窗针活检采样对胰腺神经内分泌肿瘤具有较高的敏感性,但对肿瘤分级的评估不充分:一项前瞻性研究。
Sci Rep. 2022 Apr 8;12(1):5971. doi: 10.1038/s41598-022-09923-1.
6
Reconsideration of Clinicopathologic Prognostic Factors in Pancreatic Neuroendocrine Tumors for Better Determination of Adverse Prognosis.重新审视胰腺神经内分泌肿瘤的临床病理预后因素以更好地确定不良预后
Endocr Pathol. 2021 Dec;32(4):461-472. doi: 10.1007/s12022-021-09687-w. Epub 2021 Jul 20.
7
Nerves and Pancreatic Cancer: New Insights into a Dangerous Relationship.神经与胰腺癌:对一种危险关系的新见解
Cancers (Basel). 2019 Jun 26;11(7):893. doi: 10.3390/cancers11070893.